Key Takeaways
- • Six early-stage Florida companies collectively secured $150,000 in investment awards from Space Florida at the Florida Venture Forum's 18th annual Early Stage Venture Conference held in Orlando on June 3, 2026.
- • Aloft Biotechnologies (Alachua, FL) won the Accelerating Innovation Award of $50,000 for developing next-generation biomanufacturing systems for space-based cell culture and biological production, with near-term commercialization focus on terrestrial advanced cell therapy manufacturing.
- • The conference attracted 32 selected companies from a competitive pool of nearly 300 applicants across Florida, evaluated on innovation, market opportunity, and alignment with the state's targeted high-growth sectors including aerospace, defense, and emerging technologies.
- • Winning companies become eligible for an additional $80,000 in legal services provided by wiggin(x), creating a combined value proposition beyond cash awards for participating startups.
- • The 18th annual conference reinforces Florida's positioning as a venture capital hub, with Space Florida and Florida Venture Forum serving as catalysts for early-stage company acceleration in technology-intensive sectors.
Summary
Florida Venture Forum announced the investment winners of its 18th annual Early Stage Venture Conference on June 3, 2026, distributing a combined $150,000 from Space Florida to six early-stage companies selected from a highly competitive applicant pool. The conference, held in downtown Orlando at the Fairwinds Alumni Center at UCF, attracted nearly 300 applications, from which 32 companies were selected to present to investors and industry leaders.
The evaluation process centered on three primary criteria: innovation, market opportunity, and strategic alignment with Florida's targeted high-growth sectors—particularly aerospace, defense, and emerging technologies. Aloft Biotechnologies, based in Alachua, captured the top prize with the Accelerating Innovation Award of $50,000. The company is developing proprietary biomanufacturing systems designed to enable cell culture and biological production in microgravity environments. While the company's long-term vision focuses on commercial space-based biomanufacturing, Aloft is pursuing near-term revenue through terrestrial applications in advanced cell therapy manufacturing, including active proof-of-concept collaborations with Sartorius on iPSC and T-cell bioreactor optimization.
Beyond the $150,000 in direct investment awards, Space Florida and Florida Venture Forum enhanced the value proposition for winning companies by providing $80,000 in complementary legal services via wiggin(x), positioning these startups with both capital and professional advisory infrastructure for accelerated growth and commercialization. This multi-layered support structure reflects the state's institutional commitment to fostering innovation ecosystems in aerospace, biotech, and defense technology sectors.
The conference drew a standing-room crowd of institutional investors, deal makers, and venture professionals, underscoring sustained investor interest in Florida-based early-stage opportunities. The 18th iteration of this annual event demonstrates the Florida Venture Forum's established role as the state's largest statewide support organization for investors and entrepreneurs, with Space Florida reinforcing the state's positioning in aerospace and advanced technology verticals.
The evaluation process centered on three primary criteria: innovation, market opportunity, and strategic alignment with Florida's targeted high-growth sectors—particularly aerospace, defense, and emerging technologies. Aloft Biotechnologies, based in Alachua, captured the top prize with the Accelerating Innovation Award of $50,000. The company is developing proprietary biomanufacturing systems designed to enable cell culture and biological production in microgravity environments. While the company's long-term vision focuses on commercial space-based biomanufacturing, Aloft is pursuing near-term revenue through terrestrial applications in advanced cell therapy manufacturing, including active proof-of-concept collaborations with Sartorius on iPSC and T-cell bioreactor optimization.
Beyond the $150,000 in direct investment awards, Space Florida and Florida Venture Forum enhanced the value proposition for winning companies by providing $80,000 in complementary legal services via wiggin(x), positioning these startups with both capital and professional advisory infrastructure for accelerated growth and commercialization. This multi-layered support structure reflects the state's institutional commitment to fostering innovation ecosystems in aerospace, biotech, and defense technology sectors.
The conference drew a standing-room crowd of institutional investors, deal makers, and venture professionals, underscoring sustained investor interest in Florida-based early-stage opportunities. The 18th iteration of this annual event demonstrates the Florida Venture Forum's established role as the state's largest statewide support organization for investors and entrepreneurs, with Space Florida reinforcing the state's positioning in aerospace and advanced technology verticals.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.